Here is how NeuroOne Medical Technologies Corp (NMTC) stock might take investors finances to the next level

A share price of NeuroOne Medical Technologies Corp [NMTC] is currently trading at $0.69, up 5.80%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The NMTC shares have gain 21.72% over the last week, with a monthly amount glided 4.01%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

NeuroOne Medical Technologies Corp [NASDAQ: NMTC] stock has seen the most recent analyst activity on May 05, 2025, when Ladenburg Thalmann initiated its Buy rating and assigned the stock a price target of $1.45. Previously, Craig Hallum downgraded its rating to Hold on March 29, 2022, and dropped its price target to $2.

NeuroOne Medical Technologies Corp experienced fluctuations in its stock price throughout the past year between $0.40 and $1.39. NeuroOne Medical Technologies Corp [NASDAQ: NMTC] shares were valued at $0.69 at the most recent close of the market.

Analyzing the NMTC fundamentals

Trailing Twelve Months sales for NeuroOne Medical Technologies Corp [NASDAQ:NMTC] were 8.76M which represents 0.67% growth. Gross Profit Margin for this corporation currently stands at 0.54% with Operating Profit Margin at -1.14%, Pretax Profit Margin comes in at -1.15%, and Net Profit Margin reading is -1.15%. To continue investigating profitability, this company’s Return on Assets is posted at -1.48, Equity is -3.35 and Total Capital is -2.44. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.28.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.6486 points at the first support level, and at 0.6096 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.7194, and for the 2nd resistance point, it is at 0.7512.

Ratios To Look Out For

To put it in perspective, the Current Ratio for NeuroOne Medical Technologies Corp [NASDAQ:NMTC] is 2.09. In addition, the Quick Ratio stands at 1.05 and the Cash Ratio stands at 0.75. Considering the valuation of this stock, the price to sales ratio is 3.91, the price to book ratio is 19.17.

Transactions by insiders

Recent insider trading involved Christianson Mark, Business Development Director, that happened on Jun 04 ’25 when 10000.0 shares were sold. Business Development Director, Christianson Mark completed a deal on May 22 ’25 to sell 8967.0 shares. Meanwhile, Business Development Director Christianson Mark sold 14.0 shares on May 21 ’25.

Related Posts

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.